Biotech news
Biotech
Israel-based Teva Pharmaceuticals has signed a global licence agreement with Alder BioPharmaceuticals. 11 January 2018
Americas
The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness. 11 January 2018
Americas
Celgene Corporation is to acquire Impact Biomedicines in the first quarter of 2018. 9 January 2018
Americas
Stanford University has entered into a licensing agreement with Madenco Biosciences to develop and commercialise patented epidermal growth factor wound healing technology. 5 January 2018
Americas
Biotech company Arvinas has announced a multi-year research collaboration and licence agreement with global pharmaceutical corporation Pfizer. 5 January 2018
Americas
Litigation-focused firm Robins Kaplan has promoted nine lawyers so far in 2018, including five IP lawyers in its Silicon Valley, Minneapolis, and Boston offices. 5 January 2018
Asia-Pacific
Singapore-based Aslan Pharmaceuticals has acquired the full global rights to develop, manufacture and commercialise a cancer treatment. 4 January 2018
Americas
The US Court of Appeals for the Federal Circuit has rejected Regeneron’s request for a panel rehearing and rehearing en banc in a case centring on inequitable conduct. 2 January 2018
Biotech
The UK’s most prolific inventor for 2017 has been named as Alex Powlesland, a research chemist at British biotech company Immunocore. 22 December 2017
Americas
Shire is attempting to secure a preliminary injunction against two of Roche’s subsidiaries, Genentech and Chugai Pharmaceutical. 20 December 2017